Link to the University of Pittsburgh Homepage
Link to the University Library System Homepage Link to the Contact Us Form

Depressive symptoms and cytokine levels in Serum and Tumor Tissue in patients with an Astrocytoma: A pilot study

Starkweather, AR and Sherwood, P and Lyon, DE and Bovbjerg, DH and Broaddus, WC and Elswick, RK and Sturgill, J (2014) Depressive symptoms and cytokine levels in Serum and Tumor Tissue in patients with an Astrocytoma: A pilot study. BMC Research Notes, 7 (1).

[img]
Preview
PDF
Published Version
Available under License : See the attached license file.

Download (364kB) | Preview
[img] Plain Text (licence)
Available under License : See the attached license file.

Download (1kB)

Abstract

© 2014 Starkweather et al.; licensee BioMed Central Ltd. Preoperative depressive symptoms are associated with poor outcomes in patients with an astrocytoma. Cytokines are associated with depressive symptoms in the general population and are important mediators of tumor growth and progression.The aims of this study were to: (1) characterize depressive symptoms, other treatment-related symptoms and biological mediators; and (2) determine whether preoperative depressive symptoms were associated with the selected biological mediators. Methods. A prospective, exploratory study was carried out among 22 patients with a high-grade astrocytoma. Self-report questionnaires and peripheral blood samples were collected on the day of surgery. Tumor tissue was collected intraoperatively. Self-report questionnaires were assessed at 3, 6, 9, and 12-months postoperatively. Results: In circulation, serum IL-8 was inversely correlated with depressive symptoms while IL-17 measured in tumor tissue supernatant was inversely correlated with depressive symptoms. Depressive symptoms showed a significant increase at 12 months from baseline levels and were positively associated with treatment-related symptoms at 3 months and symptom distress at 12 months post-surgery. Conclusions: In this pilot study, depressive symptoms were negatively associated with IL-8 in serum and IL-17 in tumor tissue. The changes among depressive symptoms, treatment-related symptoms and symptom distress highlight the need for multi-faceted symptom management strategies over the treatment trajectory in this patient population.


Share

Citation/Export:
Social Networking:
Share |

Details

Item Type: Article
Status: Published
Creators/Authors:
CreatorsEmailPitt UsernameORCID
Starkweather, AR
Sherwood, Pprs11@pitt.eduPRS11
Lyon, DE
Bovbjerg, DHdhb15@pitt.eduDHB15
Broaddus, WC
Elswick, RK
Sturgill, J
Centers: Other Centers, Institutes, Offices, or Units > Pittsburgh Cancer Institute
Date: 4 July 2014
Date Type: Publication
Journal or Publication Title: BMC Research Notes
Volume: 7
Number: 1
DOI or Unique Handle: 10.1186/1756-0500-7-423
Schools and Programs: School of Medicine > Medicine
School of Nursing > Nursing
Refereed: Yes
Date Deposited: 19 Dec 2016 20:19
Last Modified: 15 Oct 2017 08:55
URI: http://d-scholarship.pitt.edu/id/eprint/29537

Metrics

Monthly Views for the past 3 years

Plum Analytics

Altmetric.com


Actions (login required)

View Item View Item